BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20350665)

  • 1. Rituximab-associated neutropenia.
    Dunleavy K; Tay K; Wilson WH
    Semin Hematol; 2010 Apr; 47(2):180-6. PubMed ID: 20350665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
    Sparano JA; Lee JY; Kaplan LD; Levine AM; Ramos JC; Ambinder RF; Wachsman W; Aboulafia D; Noy A; Henry DH; Von Roenn J; Dezube BJ; Remick SC; Shah MH; Leichman L; Ratner L; Cesarman E; Chadburn A; Mitsuyasu R;
    Blood; 2010 Apr; 115(15):3008-16. PubMed ID: 20023215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
    Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
    Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
    [No Abstract]   [Full Text] [Related]  

  • 4. Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.
    Pettengell R; Bosly A; Szucs TD; Jackisch C; Leonard R; Paridaens R; Constenla M; Schwenkglenks M;
    Br J Haematol; 2009 Mar; 144(5):677-85. PubMed ID: 19055662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia associated with rituximab therapy.
    Grant C; Wilson WH; Dunleavy K
    Curr Opin Hematol; 2011 Jan; 18(1):49-54. PubMed ID: 21102324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
    Hirai Y; Ainoda Y; Shoji T; Fujita T; Yoshinaga K; Shiseki M; Mori N; Teramura M; Totsuka K; Motoji T
    Mycopathologia; 2011 Sep; 172(3):227-32. PubMed ID: 21472389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin lesions in a female patient with non-Hodgkin lymphoma].
    Ducasse VO; Pintado JA; Gordon MM; Oyonarte MC
    Enferm Infecc Microbiol Clin; 2007; 25(7):489-90. PubMed ID: 17692217
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.
    Pettengell R; Schwenkglenks M
    Leuk Lymphoma; 2011 Jun; 52(6):1133-6. PubMed ID: 21314247
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH; Delgado DJ
    Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
    Kikuchi M; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kako S; Kanda J; Nishida J; Sekiguchi N; Noto S; Kida M; Hangaishi A; Usuki K; Kanda Y
    J Chemother; 2015 Feb; 27(2):99-105. PubMed ID: 25314911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
    Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
    Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
    Boye J; Elter T; Engert A
    Ann Oncol; 2003 Apr; 14(4):520-35. PubMed ID: 12649096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.
    Case DC; Desch CE; Kalman LA; Vongkovit P; Mena RR; Fridman M; Allen B
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):354-60. PubMed ID: 17562245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
    Ennishi D; Yokoyama M; Mishima Y; Watanabe C; Terui Y; Takahashi S; Takeuchi K; Ikeda K; Tanimoto M; Hatake K
    Leuk Lymphoma; 2007 Nov; 48(11):2241-3. PubMed ID: 17990181
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
    Johnston KL; Farnen JP; Manske BR; Go RS
    Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL.
    Fisher RI
    Clin Adv Hematol Oncol; 2005 Jul; 3(7):544-6. PubMed ID: 16167036
    [No Abstract]   [Full Text] [Related]  

  • 19. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
    Kato H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
    [No Abstract]   [Full Text] [Related]  

  • 20. Late-onset neutropenia following primary treatment of diffuse large B-cell lymphoma with rituximab-containing therapy.
    Rozman S; Sonc M; Novakovic BJ
    Leuk Lymphoma; 2012 Oct; 53(10):1945-8. PubMed ID: 22563814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.